AI in Pharma Compilation Part 2

 Listen to Audio

Audio file

 

Listen Anywhere

June 2026

In this episode, listen to highlights from our most recent Artificial Intelligence-focused episodes, featuring discussions with speakers from the FDA, Sanofi, and the Open BioPharma Research and Training Institute on the potential for AI to reshape the drug lifecycle, how companies are leveraging artificial intelligence to drive quality transformation and accelerate workforce readiness, and more.

  • Guest

    David Churchward
    Head of Operations Quality Compliance and External Affairs
    AstraZeneca
    Richard Jaenisch
    Senior Director of Education, Outreach and Digital Experience
    Open Biopharma Research and Training Institute
    Tina Kiang, PhD
    Director of the Division of Regulations and Guidance in OPQ/OPPQ
    FDA
    Miguelina Matthews
    Head Quality Intelligence, Advocacy & Pharmacopoeia Affairs
    Sanofi
    Placeholder Person Graphic
    Susan Szathmary
    Executive Director
    Open Biopharma Training Institute
  • Transcript

    Download Transcript 


    1

    00:00:00,240 --> 00:00:10,080

    Welcome to the ISPE podcast, shaping the future of pharma, where ISPE supports you on your journey, fueling innovation, sharing insights, thought

    2

    00:00:10,080 --> 00:00:14,240

    leadership, and empowering a global community to reimagine what's possible.

    3

    00:00:14,240 --> 00:00:15,205

    You

    4

    00:00:15,205 --> 00:00:22,565

    shared a a use case called Plai, p l a I, at the ISPE conference.

    5

    00:00:22,565 --> 00:00:27,765

    And I understand this tool is used at scale, at Sanofi.

    6

    00:00:27,765 --> 00:00:33,750

    Can you share how the tool was taken from pilot to at scale?

    7

    00:00:33,750 --> 00:00:34,230

    The

    8

    00:00:34,230 --> 00:00:43,545

    initial pilot focused on one specific use case, where we were, trying to automate deviations and complaint trending while providing root cause

    9

    00:00:43,545 --> 00:00:44,585

    suggestions.

    10

    00:00:44,585 --> 00:00:54,585

    Traditionally, it's a very manual, process where the quality team spend hours looking for patterns across different types of events, and they spend time brainstorming what the potential

    11

    00:00:54,585 --> 00:00:55,625

    root causes could be.

    12

    00:00:55,625 --> 00:01:05,460

    But within a few months, we could see concrete results with play with faster identification of trending issues, and AI could generate

    13

    00:01:05,460 --> 00:01:10,580

    potential root cause hypotheses that allowed the investigators to to explore further.

    14

    00:01:10,580 --> 00:01:20,075

    And what it also enabled us to, bring this tool to scale was our, governance frame framework, which we call

    15

    00:01:20,075 --> 00:01:20,715

    RAISE.

    16

    00:01:20,715 --> 00:01:30,270

    So RAISE stands for responsible AI of at Sanofi Enterprise, and it really provides, the guardrails for how we can, develop, validate,

    17

    00:01:30,270 --> 00:01:33,790

    deploy AI tools across our organization.

    18

    00:01:33,790 --> 00:01:34,590

    Please

    19

    00:01:34,590 --> 00:01:38,590

    tell me about Open Biopharma Research and Training Institute.

    20

    00:01:38,590 --> 00:01:43,005

    How did it get started, and what is its scope of services today?

    21

    00:01:43,005 --> 00:01:43,485

    We

    22

    00:01:43,485 --> 00:01:47,485

    like to do that bridge between, you academia and industries since there's often a gap between them.

    23

    00:01:47,485 --> 00:01:56,580

    We wanna make sure that, you know, there are folks who are coming out of these academic institutions who are right, ready to work, ready to and and not just ready to work, like, ready to work at a at

    24

    00:01:56,580 --> 00:01:57,380

    a certain level.

    25

    00:01:57,380 --> 00:02:03,860

    One of the goals of our of our nonprofit, you know, because Open Biopharma Research and Training Institute is a nonprofit training institute.

    26

    00:02:03,860 --> 00:02:07,695

    And we also have, you know, we have a we have a core lab services.

    27

    00:02:07,695 --> 00:02:14,975

    We have our, you know, our polypractical production space, and we have our our training services that we we offer, and we also host as a venue as well.

    28

    00:02:14,975 --> 00:02:23,280

    So we have often a host leading training services and training come training from different organizations who are have industry ready training.

    29

    00:02:23,280 --> 00:02:31,360

    And though we often bring do we often work deals with them to have a a channel for all of our, apprentices and interns to be able to access that training.

    30

    00:02:31,360 --> 00:02:34,835

    So this way, then when they come out, third, that's how we say when they're industry ready.

    31

    00:02:34,835 --> 00:02:42,355

    They're they're able to do all of these other things and actually try out these different elements, work on the core lab services, and really get a real well rounded level of experience to understand

    32

    00:02:42,355 --> 00:02:44,035

    where they best fit.

    33

    00:02:44,035 --> 00:02:48,035

    Because oftentimes, it can be difficult when you're in college trying to figure out exactly what you wanna do.

    34

    00:02:48,035 --> 00:02:51,930

    And then that never really matches with whatever industry is about to do because it always changes.

    35

    00:02:51,930 --> 00:02:55,370

    You know, two years, five years, that's difficult for these things to work.

    36

    00:02:55,370 --> 00:02:57,530

    So that's Open BioPharma in a nutshell.

    37

    00:02:57,530 --> 00:03:02,755

    And, yeah, we're we're happy to be here, and it's a great it's a great organization.

    38

    00:03:02,755 --> 00:03:03,075

    How

    39

    00:03:03,075 --> 00:03:12,035

    do you see the integration of advanced AI techniques transforming drug development, regulatory submissions, and also manufacturing oversight?

    40

    00:03:12,035 --> 00:03:12,355

    I

    41

    00:03:12,355 --> 00:03:22,060

    think there are many different ways that AI could be used, You know, some of which would be actively regulated by FDA, some of it which, you know, is within your own, you know, industry's own

    42

    00:03:22,060 --> 00:03:24,940

    control systems to be able to moderate and regulate.

    43

    00:03:24,940 --> 00:03:32,855

    Given the right boundary conditions and ask the right questions, the AI can analyze the data far quicker than a human being can.

    44

    00:03:32,855 --> 00:03:33,815

    You know?

    45

    00:03:33,815 --> 00:03:36,615

    But ultimately, you know, a human being has to check it.

    46

    00:03:36,615 --> 00:03:45,940

    A human being has to make sure the boundary conditions are set correctly, that the parameters are set correctly, and that, you know, whatever comes out makes sense within the context of what you're

    47

    00:03:45,940 --> 00:03:46,500

    using.

    48

    00:03:46,500 --> 00:03:49,380

    So I think there there's a there are great opportunities.

    49

    00:03:49,380 --> 00:03:53,300

    With opportunities, there are risks, and you have to control for those risks.

    50

    00:03:53,300 --> 00:04:03,175

    But I don't think that we should shy away from those opportunities in the same way that we haven't shied away from adding or using newer technologies

    51

    00:04:03,175 --> 00:04:07,415

    and, for example, manufacturing or molecule selection that we have in the past.

    52

    00:04:07,415 --> 00:04:09,655

    We're to use process models.

    53

    00:04:09,655 --> 00:04:12,695

    We're used computational modeling in order to do molecule selection.

    54

    00:04:12,695 --> 00:04:16,400

    These I think of this as, like, the next logical step.

    55

    00:04:16,400 --> 00:04:16,640

    I've

    56

    00:04:16,640 --> 00:04:26,560

    been with, ISPE for maybe thirty years now, or even more, and it's amazing how initiatives and groups

    57

    00:04:26,560 --> 00:04:35,585

    such as yours can really drive and influence the direction of regulatory, acceptance of new technologies.

    58

    00:04:35,585 --> 00:04:45,330

    But anyways, what do you see as the biggest challenges and the biggest opportunities facing pharmaceutical manufacturing in this

    59

    00:04:45,330 --> 00:04:47,810

    age of AI powered technologies?

    60

    00:04:47,810 --> 00:04:48,370

    On

    61

    00:04:48,370 --> 00:04:51,570

    the challenge side, I think the biggest hurdle is trust.

    62

    00:04:51,570 --> 00:04:54,130

    Patient safety is nonnegotiable in our industry.

    63

    00:04:54,130 --> 00:05:00,815

    So when we talk about bringing AI into GXP environments, there's natural skepticism there.

    64

    00:05:00,815 --> 00:05:05,855

    But we think about how do we validate these systems, how do we explain what the algorithm is doing.

    65

    00:05:05,855 --> 00:05:12,430

    When a regulator asks, You know, we need to be able to explain, and how do we ensure that AI doesn't drift over time?

    66

    00:05:12,430 --> 00:05:15,150

    That's one of the biggest challenges on the challenge side.

    67

    00:05:15,150 --> 00:05:16,990

    There's also the cultural piece.

    68

    00:05:16,990 --> 00:05:26,785

    We've built our quality systems on deterministic rule based thinking for decades, and now AI is introducing probabilistic decision making that can feel

    69

    00:05:26,785 --> 00:05:29,265

    uncomfortable to some some of the users.

    70

    00:05:29,265 --> 00:05:34,225

    Predictive quality is definitely, something that's part of the future.

    71

    00:05:34,225 --> 00:05:39,390

    Instead of reacting to deviations after they happen, What if we could actually see them coming?

    72

    00:05:39,390 --> 00:05:48,030

    AI lets us analyze vast amounts of process data, and it allows us to spot patterns that humans simply can't see as easily.

    73

    00:05:48,030 --> 00:05:57,845

    So if we can use AI to streamline processes and make smarter decisions faster, that means getting, like, receiving medicines to patients sooner,

    74

    00:05:57,845 --> 00:05:58,965

    and that's a real win.

    75

    00:05:58,965 --> 00:05:59,285

    Those

    76

    00:05:59,285 --> 00:06:01,125

    opportunities are really exciting.

    77

    00:06:01,125 --> 00:06:09,680

    I guess that with with any new technology, there's there's always the question relation to guardrails that protect the patient without impeding that innovation.

    78

    00:06:09,680 --> 00:06:12,160

    Samantha, maybe you touched on a little bit there.

    79

    00:06:12,160 --> 00:06:22,000

    What do you think are the opportunities to update regulatory frameworks to keep pace with the rapid AI innovations that we're seeing, in the pharmaceutical sector?

    80

    00:06:22,000 --> 00:06:22,535

    We

    81

    00:06:22,535 --> 00:06:24,695

    always have to look for opportunities for convergence.

    82

    00:06:24,695 --> 00:06:33,735

    We have to have conversations with our fellow regulators across the globe to make sure that there's, you know, as much of a singular voice as possible.

    83

    00:06:33,735 --> 00:06:39,960

    You know, there are the points, you know, points to consider or just general guidelines that we published with EMA.

    84

    00:06:39,960 --> 00:06:46,040

    We have to look across not just within, you know, within the scope of what the FDA regulates.

    85

    00:06:46,040 --> 00:06:46,840

    You know?

    86

    00:06:46,840 --> 00:06:56,415

    We we have to use our regulatory partners to make sure that we are giving the the industry a consistent message on how to integrate, this new

    87

    00:06:56,415 --> 00:06:57,135

    technology.

    88

    00:06:57,135 --> 00:06:57,535

    Tell

    89

    00:06:57,535 --> 00:07:03,695

    me how your use of AI, is improving how you are training your students.

    90

    00:07:03,695 --> 00:07:05,900

    So

    91

    00:07:05,980 --> 00:07:14,860

    when it comes to AI, we started working with it very kind of oh, and not really early on per se because, you know, AI has been around since nineteen forties, technically speaking.

    92

    00:07:14,860 --> 00:07:15,180

    Right?

    93

    00:07:15,180 --> 00:07:21,395

    But what we're talking about when we use AI is, generally speaking, we're using, we started using generative AI.

    94

    00:07:21,395 --> 00:07:30,995

    So what that means in our case is that in 2000 in 2023, all of our we started with our, apprentices, and we went, okay.

    95

    00:07:30,995 --> 00:07:36,810

    How do we make sure to give them the readiness they need to work in the in the in the future for the future workforce.

    96

    00:07:36,810 --> 00:07:37,290

    Right?

    97

    00:07:37,290 --> 00:07:40,570

    And so what we did was we started identifying.

    98

    00:07:40,570 --> 00:07:48,410

    We saw there was a there was a paper from the federal from the Fed that explained what the strong suits and weeks and weaknesses of are these are these tools.

    99

    00:07:48,410 --> 00:07:48,890

    And we said, okay.

    100

    00:07:48,890 --> 00:07:50,335

    Well, it seems we're weak.

    101

    00:07:50,335 --> 00:07:52,095

    Research is a bit of a weak point.

    102

    00:07:52,095 --> 00:07:52,655

    Why?

    103

    00:07:52,655 --> 00:07:59,855

    And we knew that research is a very critical element, these students are learning, and these apprentices are learning how to really conduct appropriate research.

    104

    00:07:59,855 --> 00:08:01,695

    And so we wanted to really test that.

    105

    00:08:01,695 --> 00:08:11,570

    So we started doing what's called a parallel project where everything that they would do, they would have the they would train what, what we'll call an AI assistant to do at the same time.

    106

    00:08:11,570 --> 00:08:15,295

    And so they would iterate this forth back and forth, and they've been doing this for years at point.

    107

    00:08:15,295 --> 00:08:17,775

    So every cohort that comes on does the same thing.

    108

    00:08:17,775 --> 00:08:22,335

    And so everything that they're doing, when they do it, they do it in parallel with the actual AI assistant.

    109

    00:08:22,335 --> 00:08:23,615

    They create the assistant.

    110

    00:08:23,615 --> 00:08:24,735

    They build the elements in there.

    111

    00:08:24,735 --> 00:08:32,920

    And so that this way, what they're doing creates a little bit of that that tacit record kind of gets a little bit more under better understood.

    112

    00:08:32,920 --> 00:08:42,915

    Because it also means that when, inevitably, the apprentice or intern leaves because we are an institute that takes in apprentices and interns on in six month, year, two

    113

    00:08:42,915 --> 00:08:44,355

    year, they differ.

    114

    00:08:44,355 --> 00:08:46,995

    And so a project, you know, might suffer from a gap.

    115

    00:08:46,995 --> 00:08:49,635

    And so this allows the next person to kind of pop up

    116

    00:08:49,635 --> 00:08:50,275

    and go, oh, look.

    117

    00:08:50,275 --> 00:08:50,435

    Here's

    118

    00:08:50,435 --> 00:08:50,995

    the assistant.

    119

    00:08:50,995 --> 00:08:52,595

    Let's let's help them kinda carry along.

    120

    00:08:52,595 --> 00:08:54,195

    It ends up kind of carrying these gaps forward.

    121

    00:08:54,195 --> 00:09:00,280

    And so it ended up being a really useful tool to kind of carry along this tribal knowledge that normally kind of can get a little bit lost along the way.

    122

    00:09:00,280 --> 00:09:08,360

    It also meant that in this way, they were also testing their own critical thinking skills because that was one of the elements that they found out early on is that it was bad.

    123

    00:09:08,360 --> 00:09:18,095

    Early generative AI in in in 2023 was, you know, maybe at best, had to hit about a 10% ratio in terms of the

    124

    00:09:18,095 --> 00:09:21,855

    success rate to actually get the link and the name and all the rest of materials right.

    125

    00:09:21,855 --> 00:09:24,140

    Now maybe it's about 40%.

    126

    00:09:24,140 --> 00:09:25,020

    It's getting better.

    127

    00:09:25,020 --> 00:09:26,220

    And this is off the shelf tool.

    128

    00:09:26,220 --> 00:09:28,780

    So when you really hone something, and that's what they learned.

    129

    00:09:28,780 --> 00:09:31,180

    When they really honed something, they managed to make it better.

    130

    00:09:31,180 --> 00:09:33,020

    But we're not just using it there.

    131

    00:09:33,020 --> 00:09:39,075

    So that's what we started working with it there to make sure that all of our staff have a really good understanding as well as all of our apprentices.

    132

    00:09:39,075 --> 00:09:47,075

    Anyone who really walks through our doors, we wanna make sure that they're a little bit better off, you know, understanding what the AI landscape looks like and how to integrate it into their

    133

    00:09:47,075 --> 00:09:47,875

    workflows.

    134

    00:09:47,875 --> 00:09:48,195

    What

    135

    00:09:48,195 --> 00:09:51,475

    allowed this deployment to take place successfully?

    136

    00:09:51,475 --> 00:09:53,050

    But,

    137

    00:09:53,050 --> 00:10:01,130

    honestly, I think the secret sauce was treating this as a quality initiative that happened to use AI and not an AI initiative that happened to touch quality.

    138

    00:10:01,130 --> 00:10:08,905

    So we the quality teams were actively involved in, deploying the the QA platform for play, for example.

    139

    00:10:08,905 --> 00:10:10,105

    Several benefits.

    140

    00:10:10,105 --> 00:10:14,185

    First of all, there's the, of course, the speed and the efficiency piece.

    141

    00:10:14,185 --> 00:10:22,230

    So investigations, for example, which used to take hours or even days with manual tasks, that's actually,

    142

    00:10:23,590 --> 00:10:27,590

    significantly decreased in terms of the the amount of time it takes.

    143

    00:10:27,590 --> 00:10:31,750

    And beyond the speed, it's also the insights for quality.

    144

    00:10:31,750 --> 00:10:40,015

    So AI can help us spot patterns and connect to the dots for, you know, thousands of data points, more quickly than a human can.

    145

    00:10:40,015 --> 00:10:42,495

    And thirdly, there's the the consistency piece.

    146

    00:10:42,495 --> 00:10:51,220

    So, human analysis can depend, highly on who's doing the review, their experience level, and even what time of day it is.

    147

    00:10:51,220 --> 00:10:57,380

    The play tool brings a level of standardization to how we approach trending and root cause analysis.

    148

    00:10:57,380 --> 00:11:06,955

    From your perspective, how should companies prepare for inspections where AI supported decision making is integral to GMP compliance?

    149

    00:11:06,955 --> 00:11:14,475

    You know, are other new expectations for human oversight, for failure mode analysis, or or for real time monitoring?

    150

    00:11:14,475 --> 00:11:15,680

    Even

    151

    00:11:15,680 --> 00:11:22,880

    though we use the terminology of AI decision making, we have to remember that, by definition, AI is not making a decision.

    152

    00:11:22,880 --> 00:11:23,920

    It's providing output.

    153

    00:11:23,920 --> 00:11:25,280

    Human beings make decisions.

    154

    00:11:25,280 --> 00:11:35,055

    And so, you know, when we look at our regulations, you know, we're we're never if software had an output and that output was used without

    155

    00:11:35,055 --> 00:11:37,615

    human intervention, we would still call it output.

    156

    00:11:37,615 --> 00:11:44,735

    Just because AI behaves more human like, we kind of start using this this nomenclature of decision making, but it's still output.

    157

    00:11:44,735 --> 00:11:48,470

    And so, you know, ultimately, AI is a tool.

    158

    00:11:48,470 --> 00:11:51,990

    It provides output on which decisions by people are made.

    159

    00:11:51,990 --> 00:12:01,695

    And, you know, whether or not, you know, the output that is given by the AI is used without any additional human intervention or human in the

    160

    00:12:01,695 --> 00:12:02,255

    loop.

    161

    00:12:02,255 --> 00:12:03,295

    That is a decision.

    162

    00:12:03,295 --> 00:12:07,375

    That's the decision, not the output that the that was given by the AI.

    163

    00:12:07,375 --> 00:12:10,335

    And so I think that distinction needs to be clearly made.

    164

    00:12:10,335 --> 00:12:16,140

    And if that distinction is clearly made, then then the thought process about inspections becomes easier actually.

    165

    00:12:16,140 --> 00:12:19,420

    Because then you're still thinking about human beings.

    166

    00:12:19,420 --> 00:12:21,020

    You're still thinking about record keeping.

    167

    00:12:21,020 --> 00:12:30,955

    You're still thinking thinking is our is the output being given by this very advanced software still appropriate to maintain the quality of the product that comes out at the other

    168

    00:12:30,955 --> 00:12:31,435

    end?

    169

    00:12:31,435 --> 00:12:41,320

    The quality unit is ultimately responsible for the end product and for making sure that along the way, all the parts of the processes are operating the

    170

    00:12:41,320 --> 00:12:47,080

    way they should be, whether it's validation, whether it's, you know, the specifications, whether it's the output, etcetera.

    171

    00:12:47,080 --> 00:12:56,755

    And, you know, so I think, you know, once we frame the the use of the AI in the appropriate way, like, AI, yes, AI decision

    172

    00:12:56,755 --> 00:13:01,395

    making, quote, unquote, it seems like it's making a decision, but it's really AI output.

    173

    00:13:01,395 --> 00:13:06,515

    It's AI output and human decision making on what to use with that out how to use that output.

    174

    00:13:06,515 --> 00:13:07,170

    In

    175

    00:13:07,170 --> 00:13:16,610

    your presentation at the ISPE Facilities of the Future Conference, you talked about quality maturity index versus

    176

    00:13:16,930 --> 00:13:18,690

    quality risk exposure.

    177

    00:13:18,690 --> 00:13:21,075

    What exactly are they?

    178

    00:13:21,075 --> 00:13:23,475

    And how are they complementary?

    179

    00:13:23,475 --> 00:13:29,235

    And how is AI giving you better insights into these measures?

    180

    00:13:29,235 --> 00:13:30,035

    QMI

    181

    00:13:30,035 --> 00:13:38,710

    and QRE are essentially two metrics, that help us understand the complete picture of quality across our global network.

    182

    00:13:38,710 --> 00:13:48,695

    So QMI or the Quality Maturity Index is essentially a digital analytics tool, within our platform, and it provides, dynamic

    183

    00:13:48,695 --> 00:13:57,975

    data driven, essentially, KPIs that we consider to be signals for our quality maturity, at the site level.

    184

    00:13:57,975 --> 00:13:58,455

    Many

    185

    00:13:58,455 --> 00:14:08,430

    times, a deviation gets resolved, quote, unquote, by saying, well, it was operator error, and

    186

    00:14:08,430 --> 00:14:10,590

    we retrained the operator.

    187

    00:14:10,590 --> 00:14:11,310

    Yes.

    188

    00:14:11,310 --> 00:14:12,030

    Okay?

    189

    00:14:12,030 --> 00:14:21,615

    Now, so the training was inadequate to begin with, and we're gonna retrain the operator on a training system that was

    190

    00:14:21,615 --> 00:14:23,295

    inadequate to begin with.

    191

    00:14:23,295 --> 00:14:25,215

    That's the logic that I see here.

    192

    00:14:25,215 --> 00:14:32,850

    But would your AI be able to kind of cry foul and say, wait a minute.

    193

    00:14:32,850 --> 00:14:37,330

    The human error was either, okay.

    194

    00:14:37,330 --> 00:14:47,305

    The individual really screwed up or the training was not good enough or the SOP is confusing or there's

    195

    00:14:47,305 --> 00:14:52,425

    some other root cause in the manufacturing system that needs to be addressed.

    196

    00:14:52,425 --> 00:14:52,665

    Yeah.

    197

    00:14:52,665 --> 00:14:56,185

    Do you see AI getting us to that place?

    198

    00:14:56,185 --> 00:14:57,010

    Oh,

    199

    00:14:57,010 --> 00:14:57,730

    I mean, absolutely.

    200

    00:14:57,730 --> 00:14:59,490

    That's exactly before.

    201

    00:14:59,490 --> 00:15:08,930

    So so one of the things one of the first projects, you know, that because on the side, my brother and I, you know, we we we do consulting for generative AI.

    202

    00:15:08,930 --> 00:15:14,075

    And one of the things we did was one of the first projects we did was on deviations, was around deviations.

    203

    00:15:14,075 --> 00:15:18,155

    And the thing is, you know, this is something that we see commonly now.

    204

    00:15:18,155 --> 00:15:26,880

    All of the big players all have AI built into looking at their deviations because it is just it's it's a great way to summarize a lot of elements and reduce a lot of the the the hours.

    205

    00:15:26,880 --> 00:15:29,440

    It's a pretty low hanging fruit, generally.

    206

    00:15:29,440 --> 00:15:34,880

    But the thing is that part that you touched on was is not something I hear a lot about.

    207

    00:15:34,880 --> 00:15:36,415

    They always hear about, hey.

    208

    00:15:36,415 --> 00:15:39,135

    I'm moving it, but they're like, ah, but we don't wanna solve the problem, though.

    209

    00:15:39,135 --> 00:15:39,295

    That

    210

    00:15:39,295 --> 00:15:40,255

    that part is a

    211

    00:15:40,255 --> 00:15:43,295

    bit absent, which is unfortunate because I think it's such a missed opportunity.

    212

    00:15:43,295 --> 00:15:44,495

    And I think you're right.

    213

    00:15:44,495 --> 00:15:53,510

    I and I think this is one of the areas where, you know, we're going to see our when our deviations come out come into play, and we see that element that says, hey.

    214

    00:15:53,510 --> 00:15:54,790

    This is a human error.

    215

    00:15:54,790 --> 00:15:59,350

    We happen to have the training record that's very transparent, that's very that's very traceable test.

    216

    00:15:59,350 --> 00:15:59,830

    Oh, look.

    217

    00:15:59,830 --> 00:16:04,790

    Looks like they're we see right here that they're missing this specific pipetting skill.

    218

    00:16:04,790 --> 00:16:09,645

    What we see now why this did not work, well, because they're not doing very well in this.

    219

    00:16:09,645 --> 00:16:15,565

    Let's go back and retrain them on this specific area so we don't have to waste time with all the rest of this because this is the real weak point.

    220

    00:16:15,565 --> 00:16:19,120

    Focus on that, and then we'll probably see a lot better results.

    221

    00:16:19,120 --> 00:16:23,680

    Now I say probably because we haven't instituted that yet, but we will see that happen in the future.

    222

    00:16:23,680 --> 00:16:23,840

    I'm

    223

    00:16:23,840 --> 00:16:24,400

    certain of it.

    224

    00:16:24,400 --> 00:16:34,205

    How is AI helping you move complaints and deviations from being a reactive process to a predictive process.

    225

    00:16:34,205 --> 00:16:35,645

    It's

    226

    00:16:35,965 --> 00:16:41,245

    more difficult for humans to to see the patterns and to, do this in an in a manual way.

    227

    00:16:41,245 --> 00:16:51,100

    With play, it can analyze thousands of historical deviations and complaints and identify early warning signals that proceed major

    228

    00:16:51,100 --> 00:16:52,220

    quality events.

    229

    00:16:52,220 --> 00:17:00,620

    So maybe, for example, we'll see an uptick in a certain type of minor deviation that historically has led to more serious issues

    230

    00:17:01,835 --> 00:17:05,195

    or a particular combination of fact of factors.

    231

    00:17:05,195 --> 00:17:09,675

    For example, equipment, product line, shifting of time.

    232

    00:17:09,675 --> 00:17:12,315

    So that correlates with problems down the road.

    233

    00:17:12,315 --> 00:17:16,280

    So humans simply can't process that volume of data to spot the patterns.

    234

    00:17:16,280 --> 00:17:18,920

    So AI is really allowing us to do that.

    235

    00:17:18,920 --> 00:17:19,480

    Thinking

    236

    00:17:19,480 --> 00:17:29,480

    about the regulatory filing, what are the most common challenges that reviewers might encounter when evaluating AI driven evidence or models in in

    237

    00:17:29,480 --> 00:17:30,520

    those CMC submissions?

    238

    00:17:30,520 --> 00:17:31,215

    As

    239

    00:17:31,215 --> 00:17:34,655

    with anything challenging, it's, you know, something is new.

    240

    00:17:34,655 --> 00:17:38,815

    There's always challenges of, you know, what what do we need to look at?

    241

    00:17:38,815 --> 00:17:40,495

    How deeply do we need to look?

    242

    00:17:40,495 --> 00:17:50,450

    But when we're looking at the credibility framework and the risk framework, we I think we need to make sure that products are well validated, that they're fit for use, that they're correct for

    243

    00:17:50,450 --> 00:17:55,010

    the context of use, that the risk is appropriate for that part of the system.

    244

    00:17:55,010 --> 00:17:55,490

    A

    245

    00:17:55,490 --> 00:18:04,175

    number of companies, including CAI, where I sit on the board of directors, have created AI powered apps for,

    246

    00:18:04,655 --> 00:18:06,575

    deviation report writing.

    247

    00:18:06,575 --> 00:18:13,855

    How is Sanofi using AI for such tasks, and what benefits are you seeing?

    248

    00:18:13,855 --> 00:18:14,175

    RA

    249

    00:18:14,175 --> 00:18:23,910

    tools can help to draft the initial report sections and can suggest investigation pathways based on similar historical cases, and it can even help

    250

    00:18:23,910 --> 00:18:28,390

    ensure that we're covering all the regulatory requirements for the investigation.

    251

    00:18:28,390 --> 00:18:37,265

    But we're also applying this to regulatory submissions, quality assessments, and even internal quality reviews.

    252

    00:18:37,265 --> 00:18:47,260

    So the AI tools that we're using can pull relevant data from multiple systems, identify key trends, and generate draft content that our quality professionals

    253

    00:18:47,260 --> 00:18:49,660

    can then refine and and validate.

    254

    00:18:49,660 --> 00:18:50,220

    How

    255

    00:18:50,300 --> 00:18:59,305

    is the FDA addressing concerns about things like bias, transparency, and explainability in the models that are used for regulatory decision making.

    256

    00:18:59,305 --> 00:18:59,785

    The

    257

    00:18:59,785 --> 00:19:08,425

    training and their skill sets are still essential because, as with anything, if you're not trained well, you don't know what you don't know.

    258

    00:19:08,425 --> 00:19:17,370

    While we use tools, some tools, we have I think, you know, everyone knows that Elsa is the tool that's used, that that FDA has,

    259

    00:19:18,090 --> 00:19:28,025

    built, our AI, chatbot or, you know you know, and there are plug ins that can that can be utilized with Elsa to help with certain parts of

    260

    00:19:28,025 --> 00:19:31,065

    the review or certain parts of looking at policy documents.

    261

    00:19:31,065 --> 00:19:40,540

    We have a number of RAG libraries with documents where, you know, you can focus your inquiries so that there isn't, like, kind of this hallucination from all of the

    262

    00:19:40,540 --> 00:19:41,180

    Internet.

    263

    00:19:41,180 --> 00:19:44,460

    Although I'm assured that, Elsa is blocked off from the Internet.

    264

    00:19:44,460 --> 00:19:47,500

    So if we upload a document, it's not going out into the wide world.

    265

    00:19:47,500 --> 00:19:50,060

    So I wanna make sure that people do understand that as well.

    266

    00:19:50,060 --> 00:19:57,305

    But it was trained on the Internet, so there is information that could potentially cause hallucinations.

    267

    00:19:57,305 --> 00:20:02,265

    And so we have other tools where we can use it, where we can focus it on a RAG library.

    268

    00:20:02,265 --> 00:20:05,305

    Like, this is our RAG library of quality policy.

    269

    00:20:05,305 --> 00:20:09,070

    We want to make a new call policy statement about x.

    270

    00:20:09,070 --> 00:20:18,955

    We can point to that regulatory that RAG library so that the output that we get is based on the information that's there and not and won't contain

    271

    00:20:18,955 --> 00:20:25,515

    any of the noise that possibly opinion pieces on the Internet about how certain things should be regulated get seeked their way through.

    272

    00:20:25,515 --> 00:20:29,115

    But that output still needs to be checked by a person.

    273

    00:20:29,115 --> 00:20:32,555

    And, ultimately, that person who is doing the work is the one that's responsible.

    274

    00:20:32,555 --> 00:20:34,040

    And so we have to say, okay.

    275

    00:20:34,040 --> 00:20:43,880

    Do you still have the knowledge and skills to be able to look at this statement that comes out or this analysis that comes out if you're looking at data,

    276

    00:20:43,960 --> 00:20:47,240

    graph, or whatever that comes out, table that comes out?

    277

    00:20:47,240 --> 00:20:52,725

    Do you still have the skills and knowledge to look at it and say, yes.

    278

    00:20:52,725 --> 00:20:55,205

    This makes sense, and this is what I want.

    279

    00:20:55,205 --> 00:20:55,685

    Or, no.

    280

    00:20:55,685 --> 00:20:57,685

    This actually doesn't make sense.

    281

    00:20:57,685 --> 00:21:02,005

    And, you know, perhaps we need to change it or maybe I have to change my prompt.

    282

    00:21:02,005 --> 00:21:05,250

    And so there's a lot of prompt engineering going on.

    283

    00:21:05,250 --> 00:21:14,690

    You know, we have work groups to work on prompt engineering to make sure that the output is appropriately worded or formatted in the, appropriate way for the work that we're doing.

    284

    00:21:14,690 --> 00:21:21,865

    There are different tools for different assessors, for different stages of assessment that are currently being developed and tested.

    285

    00:21:21,865 --> 00:21:23,705

    Some of them have been deployed.

    286

    00:21:23,705 --> 00:21:25,785

    Some of them, you know, are still being tested.

    287

    00:21:25,785 --> 00:21:35,610

    And so I think that continuing to validate in the same way that we we want you to validate to make sure that the outputs that we could potentially use are

    288

    00:21:35,610 --> 00:21:37,850

    still appropriate for the work that we do.

    289

    00:21:37,850 --> 00:21:47,695

    But it comes down to whoever is the one who's who's utilizing that AI still needs to have that background, that historical knowledge, the training

    290

    00:21:47,695 --> 00:21:51,135

    in order to make sure that the output is appropriate for the work.

Listen to Past Episodes

Audio file

In this episode, listen to highlights from our most recent Artificial Intelligence-focused episodes, featuring discussions with speakers from the FDA, Sanofi, and the Open BioPharma Research and Training Institute on the potential for AI to reshape

Audio file

In this episode, Miguelina Matthews, Head of Quality Intelligence, Advocacy and Pharmacopoeia Affairs at Sanofi, joins the podcast to share how the company is leveraging artificial intelligence to shift pharmaceutical quality management from reactive